Gheiler E L, Tiguert R
Department of Urology, University of Miami School of Medicine, Sylvester Comprehensive Cancer Institute, Florida, USA.
World J Urol. 2000 Jun;18(3):190-3. doi: 10.1007/s003459900099.
Androgen deprivation therapy has become the mainstay treatment for locally advanced and metastatic prostate cancer. Castrate testosterone levels can be achieved by a multitude of treatments. We performed a medline literature search to answer the question, is there a "best" endocrine treatment? In conclusion we found that the "best" endocrine therapy for advanced prostate cancer is complete androgen blockade (CAB) with a luteinizing hormone-releasing hormone (LHRH) agonist and a nonsteroidal antiandrogen.
